CVM

Cel-Sci Corporation
Data: 2026-02-02
$5.4
Price
-6.64%
Change
$20.409
52W High
$1.98
52W Low

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Quick Stats
Feb 02, 2026

54.3

AI Score

HOLD

0.94

Volume Ratio

Feb 13, 2026

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

CVM Stock Summary

Last updated Feb 02, 2026

CVM is currently trading at $5.4, positioned below its 200-day moving average of $6.71, suggesting bearish momentum. The stock has a 52-week range of $1.98 to $20.409.

Technical Analysis: The 50-day moving average stands at $5.86, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.957, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.181, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CVM at 54.3/100 with a HOLD recommendation.

CVM (Cel-Sci Corporation) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 44.957
CMF (20) -0.181
ROC (10) 4.854
ADX (14) 19.935
Indicator Value
MACD (12,26,9) 0.029
AROONOSC (14) 42.857
WILLAMS %R (14) -72.973
MFI (14) 59.248
CVM Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CVM Price vs Max Options Open Interest
CVM Max Change In Options Open Interest

CVM Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CVM Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CVM Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CVM Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Cel-Sci Corporation is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CVM Moving Averages Analysis

CVM (Cel-Sci Corporation) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 5.88
20 5.69
30 5.46
50 5.86
100 7.56
200 6.71

CVM Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 48.8 million
Earnings/Share ($) -6.19
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.5
EPS Estimate Next Year ($) -0.92
WallStreet Target Price ($) 42.5
Most Recent Quarter